Simplex Trading, LLC Ultragenyx Pharmaceutical Inc. Transaction History

Simplex Trading, LLC

$2.81 Billion
Q3 2024

A detailed history of Simplex Trading, LLC transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 10,347 shares of RARE stock, worth $463,028. This represents 0.02% of its overall portfolio holdings.

Number of Shares

10,347

Previous 4,835 114.0%

Holding current value

$463,028

Previous $198,000 189.9%

% of portfolio

0.02%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$40.21 - $59.36 $221,637 - $327,192	5,512 Added 114.0%	10,347 $574,000
Q2 2024 Jul 25, 2024	BUY	$37.42 - $51.61 $145,227 - $200,298	3,881 Added 406.81%	4,835 $198,000
Q1 2024 Apr 25, 2024	BUY	$43.02 - $53.69 $41,041 - $51,220	954 New	954 $44,000
Q1 2022 May 02, 2022	SELL	$62.2 - $84.4 $5,846 - $7,933	-94 Closed	0 $0
Q4 2021 Feb 23, 2022	SELL	$73.71 - $87.86 $1,769 - $2,108	-24 Reduced 20.34%	94 $7,000
Q2 2021 Aug 12, 2021	SELL	$92.19 - $115.71 $25,997 - $32,630	-282 Reduced 70.5%	118 $11,000
Q1 2021 Apr 26, 2021	BUY	$106.9 - $167.73 $42,760 - $67,092	400 New	400 $45,000
Q3 2020 Oct 14, 2020	SELL	$72.98 - $90.0 $1.72 Million - $2.12 Million	-23,579 Closed	0 $0
Q2 2020 Jul 13, 2020	BUY	$46.91 - $78.22 $389,071 - $648,756	8,294 Added 54.26%	23,579 $1.84 Million
Q1 2020 Apr 29, 2020	BUY	$33.8 - $62.9 $84,939 - $158,067	2,513 Added 19.68%	15,285 $679,000
Q4 2019 Feb 05, 2020	BUY	$36.08 - $45.83 $59,856 - $76,031	1,659 Added 14.93%	12,772 $545,000
Q3 2019 Oct 15, 2019	BUY	$42.5 - $63.11 $472,302 - $701,341	11,113 New	11,113 $475,000
Q2 2019 Jul 26, 2019	SELL	$54.93 - $74.36 $197,363 - $267,175	-3,593 Closed	0 $0
Q1 2019 Apr 18, 2019	BUY	$39.87 - $69.36 $143,252 - $249,210	3,593 New	3,593 $0
Q4 2018 Jan 16, 2019	SELL	$38.89 - $77.3 $32,317 - $64,236	-831 Closed	0 $0
Q3 2018 Oct 23, 2018	BUY	$71.81 - $90.15 $59,674 - $74,914	831 New	831 $63,000
Q2 2018 Jul 30, 2018	SELL	$48.54 - $85.31 $130,863 - $229,995	-2,696 Closed	0 $0
Q1 2018 Apr 26, 2018	BUY	$44.33 - $58.52 $119,513 - $157,769	2,696 New	2,696 $137,000

Others Institutions Holding RARE

# of Institutions

325

Shares Held

85.7M

Call Options Held

520K

Put Options Held

406K

View Full List

About Ultragenyx Pharmaceutical Inc.

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.13B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

More about RARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account

Simplex Trading, LLC Ultragenyx Pharmaceutical Inc. Transaction History